| 摘要: |
| 目的 探究负压封闭引流术(vacuum sealing drainage,VSD)联合重组人表皮生长因子(recombinant human epidermal growth factor,rhEGF)治疗慢性难愈性创面的临床效果及对患者创面修复因子的影响。方法 研究选取2022年3月~2023年9月我院烧伤科收治的80例慢性难愈性创面患者,随机将其分为对照组与联合治疗组,每组各40例。所有患者入院后均接受外科常规治疗,其中对照组在常规治疗的基础上采用VSD进行治疗,联合治疗组则在常规治疗的基础上采用VSD联合rhEGF进行治疗,观察比较两组治疗2周后的临床疗效,治疗前后数字等级评定量表(numerical rating scale,NRS)疼痛评分情况、感染控制水平、创面细菌培养阳性情况、创面修复因子水平,两组创面完全愈合时间、住院时间以及住院费用等情况。结果 对比显示,联合治疗组患者的治疗总有效率明显高于对照组(P<0.05);治疗2周后,两组NRS疼痛评分、血清CRP、WBC、ESR水平较治疗前均明显降低(P<0.05),其中联合治疗组治疗2周后NRS疼痛评分以及血清CRP、WBC、ESR水平较对照组更低(P<0.05);通过对比得出,治疗2周后,两组创面细菌阳性情况均低于治疗前(P<0.05),其中联合治疗组患者的创面细菌转阴率(81.48%)高于对照组(48.00%)(χ2=6.429,P=0.011);治疗2周后,两组创面修复因子PDGF、EGF、VEGF、bFGF水平较治疗前均明显提升(P<0.05),其中联合治疗组治疗2周后肉芽组织中PDGF、EGF、VEGF、bFGF水平明显高于对照组(P<0.05);通过对比显示,联合治疗组的创面愈合时间及住院时间均较对照组更短(P<0.05),住院费用较对照组更少(P<0.05)。结论 VSD联合rhEGF治疗慢性难愈性创面疗效显著,能够进一步提高治疗总有效率,改善疼痛与感染控制,促进创面修复因子表达,加速愈合,缩短住院时间并减少费用,是高效经济的治疗选择。 |
| 关键词: 负压封闭引流术 重组人表皮生长因子 慢性难愈性创面 临床效果 创面修复因子 |
| DOI:10.13506/j.cnki.jpr.2025.09.016 |
| 基金项目: |
|
Publication Date:September 25, 2025
|
|
| Clinical efficacy of negative pressure wound therapy combined with rhEGF in the treatment of chronic non-healing wounds and its impact on wound healing factors |
| FU Xiaoxiao,BIAN Chenghao,WANG Huiying,ZHAO Huanjun |
| (Department of Burn,Beijing Luhe Hospital Affiliated to Capital Medical University, Beijing 101199,China) |
| Abstract: |
| Objective To explore the clinical effect of negative pressure closed drainage (vacuum sealing drainage,VSD) combined with recombinant human epidermal growth factor (rhEGF) in the treatment of chronic refractory wounds and the influence of wound repair factors on patients. Methods The study selected 80 patients with chronic non-healing wounds admitted to the burn department of our hospital from March 2022 to September 2023. They were randomly divided into a control group and a combination therapy group, with 40 patients in each group. All patients received conventional surgical treatment upon admission.The control group was treated with VSD on the basis of conventional treatment, while the combined treatment group was treated with VSD combined with rhEGF on the basis of conventional treatment. The clinical efficacy of the two groups after 2 weeks of treatment was observed and compared. Observe and compare the clinical efficacy of the two groups after 2 weeks of treatment, the pain score of the numerical rating scale (NRS) before and after treatment, the level of infection control, the positive bacterial culture of the wound surface, the level of wound repair factors, the complete healing time of the wound surface, the length of hospital stay and the hospitalization cost of the two groups, etc.Results The comparison showed that the total effective rate of treatment in the combination therapy group was significantly higher than that in the control group (P<0.05). After 2 weeks of treatment, the NRS pain score, serum CRP, WBC and ESR levels of both groups were significantly decreased compared with those before treatment (P<0.05), and the NRS pain score and serum CRP, WBC and ESR levels of the combined treatment group were lower than those of the control group after 2 weeks of treatment (P<0.05). The results showed that after 2 weeks of treatment, the positive rate of wound bacteria in both groups was lower than before treatment (P<0.05), and the rate of wound bacteria turning negative in the combined treatment group (81.48%) was higher than that in the control group (48.00%) (χ2=6.429, P=0.011). After 2 weeks of treatment, the levels of wound repair factors PDGF, EGF, VEGF and bFGF in both groups were significantly increased compared with those before treatment (P<0.05), the levels of PDGF, EGF, VEGF and bFGF in the combined treatment group were significantly higher than those in the control group after 2 weeks of treatment (P<0.05).The comparison showed that the wound healing time and hospital stay in the combined treatment group were shorter than those in the control group (P<0.05), and the hospitalization cost was less than that in the control group (P<0.05).Conclusion The combination of VSD and rhEGF in the treatment of chronic non-healing wounds demonstrates significant efficacy, further improving the total effective rate of treatment, alleviating pain, enhancing infection control, promoting the expression of wound healing factors, accelerating healing, shortening hospital stay, and reducing costs. It is an efficient and economical treatment option. |
| Key words: Negative pressure sealing drainage Recombinant human epidermal growth factor Chronic refractory wounds Clinical effect Wound repair factor |